Oct 27 (Reuters) - Kazia Therapeutics Ltd (KZA) :
- KAZIA'S PAXALISIB DEMONSTRATES POSITIVE MONOTHERAPY EFFICACY SIGNALS IN PRECLINICAL MODELS OF MELANOMA
News: KZA Kazia's Paxalisib Demonstrates Positive Monotherapy Efficacy Signals In Preclinical...
Add to My Watchlist
What is My Watchlist?